These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8195848

  • 21. A preliminary comparison of erythromycin, co-trimoxazole and amoxycillin in patients with acute exacerbations of chronic bronchitis admitted to hospital.
    Knowles GK, Milton AF, Fawcett IW, Davies RJ.
    J Int Med Res; 1980; 8 Suppl 2():51-8. PubMed ID: 6968697
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS, Ramirez-Ronda C, Saavedra S, Rivera-Vázquez CR, Liu C, Hinthorn DR.
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [Abstract] [Full Text] [Related]

  • 23. A multicenter comparative study of brodimoprim and amoxicillin therapy in the treatment of tonsillopharyngitis in adults.
    Nyffenegger R, Riebenfeld D, Bandau KH, Nouri ME, Schirmböck U, Streppel M.
    J Chemother; 1993 Dec; 5(6):512-6. PubMed ID: 8195847
    [Abstract] [Full Text] [Related]

  • 24. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [Abstract] [Full Text] [Related]

  • 25. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
    Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VZ, Voelker M.
    Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 27. [The chemotherapeutic treatment with co-trimoxazole i.m. An experience report from 12 established physicians].
    Langhans J.
    Fortschr Med; 1981 Jun 25; 99(24):966-8. PubMed ID: 6973526
    [Abstract] [Full Text] [Related]

  • 28. Comparative antibacterial spectrum of trimethoprim and brodimoprim.
    Amyes SG.
    J Chemother; 1993 Dec 25; 5(6):417-21. PubMed ID: 8195832
    [Abstract] [Full Text] [Related]

  • 29. A multi-centre study comparing trimethoprim with co-trimoxazole in the treatment of respiratory tract infection in general practice.
    Ashford JJ, Downey LJ.
    Br J Clin Pract; 1982 Apr 25; 36(4):152-6. PubMed ID: 6983363
    [No Abstract] [Full Text] [Related]

  • 30. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO, Ohaju-Obodo J.
    West Afr J Med; 1996 Apr 25; 15(2):111-6. PubMed ID: 8855675
    [Abstract] [Full Text] [Related]

  • 31. Preclinical toxicology and safety pharmacology of brodimoprim in comparison to trimethoprim and analogs.
    Stephan-Güldner M.
    J Chemother; 1993 Dec 25; 5(6):400-10. PubMed ID: 8195831
    [Abstract] [Full Text] [Related]

  • 32. Use of a new erythromycin product--eryc--in the treatment of the lower respiratory tract infections.
    Adám A, Kuberka Z.
    Ther Hung; 1990 Dec 25; 38(4):152-5. PubMed ID: 2094053
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic efficacy and tolerability of brodimoprim in comparison with doxycycline in acute sinusitis in adults.
    Arndt J, Riebenfeld D, Maier H, Weidauer H.
    J Chemother; 1994 Oct 25; 6(5):322-7. PubMed ID: 7861197
    [Abstract] [Full Text] [Related]

  • 34. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children.
    Kabir I, Khan WA, Haider R, Mitra AK, Alam AN.
    J Diarrhoeal Dis Res; 1996 Dec 25; 14(4):243-7. PubMed ID: 9203786
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of azithromycin in the treatment of acute infraorbital space infection.
    Al-Belasy FA, Hairam AR.
    J Oral Maxillofac Surg; 2003 Mar 25; 61(3):310-6. PubMed ID: 12618970
    [Abstract] [Full Text] [Related]

  • 36. Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseases.
    Danesi R, Del Tacca M.
    Int J Clin Pharmacol Res; 1985 Mar 25; 5(3):175-9. PubMed ID: 4018951
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the clinical efficacy of erythromycin, amoxicillin and co-trimoxazole in the treatment of acute respiratory tract infections in paediatric patients.
    Bottone E, Baldini G, Macchia P, Soldateschi M, Fridlevski A.
    Curr Med Res Opin; 1982 Mar 25; 8(2):67-74. PubMed ID: 6980775
    [Abstract] [Full Text] [Related]

  • 38. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS, Jones RN.
    Expert Rev Anti Infect Ther; 2007 Feb 25; 5(1):29-43. PubMed ID: 17266451
    [Abstract] [Full Text] [Related]

  • 39. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F.
    J Chemother; 1995 Jun 25; 7 Suppl 2():129-35. PubMed ID: 8622101
    [Abstract] [Full Text] [Related]

  • 40. Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease.
    Pozzi E, De Rose V.
    J Chemother; 1991 Jan 25; 3 Suppl 1():213-7. PubMed ID: 12041768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.